Universal Diagnostics S.A.
Biotechnology ResearchAndalusia, Spain51-200 Employees
Universal Diagnostics S.A. is a biotechnology research company headquartered in Sevilla, Andalusia, Spain. It develops minimally invasive, blood-based tests intended to detect cancer early, when treatment options are more plentiful and survival outcomes are improved. The company’s platform is designed to identify several cancer types through a single blood test, including colorectal, prostate, liver, pancreatic, lung, and breast cancers. Its first marker panel targets colorectal cancer screening and flags individuals who should be referred for colonoscopy. The assays rely on methylation marker panels and use routine blood samples that can be processed in reference laboratories or hospitals with standard equipment, with results uploaded to the UDX Cloud for final algorithmic analysis. To develop and execute its R&D and operations, UDX partners with international research institutions, hospitals, universities, and biobanks around the world.
1-888-653-2347 
support@leadiq.com 
